News Releases

Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.

Organization also premieres a suite of new products designed to improve operational efficiency and drive clinical excellence. NYON, Switzerland—(June 12, 2017) — Today at the 22nd IFCC-EFLM...

Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis BREA, Calif. — (April 20, 2017) — Beckman Coulter Diagnostics announced a...

Beckman Coulter Diagnostics announces FDA clearance and U.S. commercial launch of its new DxC 700 AU chemistry analyzer. The new system brings together the advanced capabilities of two successful...

DETROIT, Mich — (Dec. 16, 2016) — Henry Ford Health System Pathology and Laboratory Medicine today announced a partnership with Beckman Coulter Inc. that enhances and streamlines operations by...

BREA, Calif. — (Oct. 21, 2016) — Atlanta's Grady Health System is the first in the Southeastern United States to improve its patient care through Beckman Coulter's multi-disciplinary Power...

BREA, Calif. — (Oct. 17, 2016) — Beckman Coulter Diagnostics is pleased to announce FDA clearance and the commercial release of its new Access TSH (3rd IS) assay for use with the Access Family...

BREA, Calif. — (Oct. 13, 2016) — PCL Alverno (Hammond, Ind.), recipient of the prestigious ADVANCE Laboratory of the Year award for 2016, will share its strategies for implementing a culture...

SALUGGIA (VC) and BREA, Calif. (USA) — (August 30, 2016) — DiaSorin (FTSE Italia Mid Cap: DIA), a global leader in in vitro diagnostics immunoassay specialty testing, and Beckman Coulter...

Beckman Coulter Addresses Critical Factors for Clinical Laboratories to Move Healthcare Forward BREA, Calif. — (August 2, 2016) — Today at the 68th AACC Annual Scientific Meeting and Clinical...